T. Rowe Price Investment Management, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,507,296 shares of ARWR stock, worth $49.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,507,296
Previous 3,574,573
29.86%
Holding current value
$49.9 Million
Previous $69.2 Million
31.92%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding ARWR
# of Institutions
305Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$312 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$242 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$221 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$120 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$104 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.11B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...